NCT02064764View on ClinicalTrials.gov

Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 19, 2021

Study Completion Date

April 19, 2021

Conditions
Atrial FibrillationHypertension
Interventions
DEVICE

Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter

DEVICE

Arctic Front Advance™ Cardiac Cryoablation System

Trial Locations (10)

10016

NYU Langone Medical Center, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

18901

Doylestown Hospital, Doylestown

43210

The Ohio State University, Columbus

49855

UPHS-Marquette, Marquette

66421

Universitätsklinikum des Saarlandes, Homburg

95819

Mercy Medical Group-Cardiology, Sacramento

98101

Virginia Mason Medical Center, Seattle

01805

Lahey Hospital and Medical Center, Burlington

98122-5711

Swedish Medical Center Cherry Hill, Seattle

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT02064764 - Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter